Skip to product information
1 of 1

NSJ Bioreagents

SKU:F53909-0.05ML

ARD1A Antibody / NAA10

ARD1A Antibody / NAA10

Regular price $205.00 USD
Regular price Sale price $205.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

N-alpha-acetyltransferase 10 is the catalytic subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Without NAA15, displays epsilon (internal) acetyltransferase activity towards HIF1A, thereby promoting its degradation. Represses MYLK kinase activity by acetylation, and thus represses tumor cell migration. Acetylates, and stabilizes TSC2, thereby repressing mTOR activity and suppressing cancer development.

Specifications

Family Primary antibody
Formulation In 1X PBS, pH 7.4, with 0.09% sodium azide
Format Antigen affinity purified
Host Animal Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit Ig
Species Reactivity Human
Predicted Species Reactivity Mouse, Bovine
Application WB
Application Details Western blot: 1:1000-2000
Application Note Titration of the NAA10 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Immunogen A portion of amino acids 135-167 from the human protein was used as the immunogen for the NAA10 antibody.
Purity Antigen affinity
Storage Aliquot the NAA10 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This NAA10 antibody is available for research use only.
Uniprot # P41227
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/ard1a-antibody-naa10-f53909
Title ARD1A Antibody / NAA10
Description N-alpha-acetyltransferase 10 is the catalytic subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Without NAA15, displays epsilon (internal) acetyltransferase activity towards HIF1A, thereby promoting its degradation. Represses MYLK kinase activity by acetylation, and thus represses tumor cell migration. Acetylates, and stabilizes TSC2, thereby repressing mTOR activity and suppressing cancer development.
View full details